Cargando…
Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and Survival
BACKGROUND: Cachexia is an inflammatory and metabolic syndrome of unintentional weight loss through depletion of muscle and adipose tissue. There is limited knowledge of how chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids affect cachexia development. The purpose of...
Autores principales: | Olaechea, Santiago, Gilmore, Anne, Alvarez, Christian, Gannavarapu, Bhavani S., Infante, Rodney, Iyengar, Puneeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210667/ https://www.ncbi.nlm.nih.gov/pubmed/35747801 http://dx.doi.org/10.3389/fonc.2022.922418 |
Ejemplares similares
-
Primary Tumor Fluorine‐18 Fluorodeoxydglucose ((18)F‐FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival
por: Olaechea, Santiago, et al.
Publicado: (2022) -
A preponderance of gastrointestinal cancer patients transition into cachexia syndrome
por: Gilmore, Linda Anne, et al.
Publicado: (2022) -
Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia
por: Gandhi, Aakash Y., et al.
Publicado: (2022) -
From NSAIDs to Glucocorticoids and Beyond
por: Sinniah, Ajantha, et al.
Publicado: (2021) -
When to stop anticoagulation, anti-platelet aggregates, and non-steroidal anti-inflammatories (NSAIDs) prior to spine surgery
por: Epstein, Nancy E.
Publicado: (2019)